WITHUS PHARMACEUTICAL Co.,LTD. (KOSDAQ: 330350)
South Korea
· Delayed Price · Currency is KRW
6,820.00
+20.00 (0.29%)
Dec 27, 2024, 9:00 AM KST
WITHUS PHARMACEUTICAL Co.,LTD. Revenue
WITHUS PHARMACEUTICAL Co.,LTD. had revenue of 27.64B KRW in the quarter ending September 30, 2024, with 37.01% growth. This brings the company's revenue in the last twelve months to 105.74B, up 53.30% year-over-year. In the year 2023, WITHUS PHARMACEUTICAL Co.,LTD. had annual revenue of 80.12B with 23.87% growth.
Revenue (ttm)
105.74B
Revenue Growth
+53.30%
P/S Ratio
0.87
Revenue / Employee
873.87M
Employees
121
Market Cap
92.55B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 80.12B | 15.44B | 23.87% |
Dec 31, 2022 | 64.68B | 7.26B | 12.65% |
Dec 31, 2021 | 57.42B | 4.01B | 7.51% |
Dec 31, 2020 | 53.41B | 1.01B | 1.93% |
Jun 30, 2020 | 52.39B | 661.12M | 1.28% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Electronics | 292.86T |
SK hynix | 57.73T |
LG Energy Solution | 27.17T |
Samsung Biologics Co.,Ltd. | 4,364.39B |
Hyundai Motor Company | 170.28T |
Kia Corporation | 104.63T |
Celltrion | 2,876.25B |
KB Financial Group | 14.11T |